Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
A multicenter, parallel, randomized, placebo (double-blind) and pirfenidone (open-label) controlled Phase III clinical trial to evaluate the efficacy and safety of HEC585 in patients with idiopathic pulmonary fibrosis (IPF)
Epistemonikos ID: bd0a2fa16e003ad373a32fb0cff5e704a36f50d6
First added on: Jul 25, 2025